Purchase this article with an account.
S. Pujari, K. Quinones, C. S. Foster; Pattern of Uveitis Associated Macular Edema as a Factor Affecting Response to Intravitreal Bevacizumab. Invest. Ophthalmol. Vis. Sci. 2008;49(13):4731.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To assess the response to bevacizumab in different patterns of uveitic macular edema.
34 eyes with uveitic macular edema receiving single (25 eyes) or two doses of bevacizumab intravitreal injections (2.5mg) were prospectively followed for 6 months. Anatomical outcomes were assessed by OCT.
Three patterns of macular edema were identified and percentages of eyes showing response (defined as 25% reduction in central foveal thickness) are as follows:diffuse thickening, 29%(4/14) , cystoid edema,56%(9/16), serous detachment without posterior hyaloid traction,50%(2/4). Four eyes each having diffuse thickening and cystoid edema and one eye having serous detachment without posterior hyaloid traction received second doze of intravitreal bevacizumab.
This PDF is available to Subscribers Only